Group 1 - The core viewpoint of the news highlights the performance of the China Securities Pharmaceutical and Medical Device Innovation Index, with notable gains from stocks like Hualan Biological and Yingke Medical, while the Medical Innovation ETF has seen a slight decline [1] - The Medical Innovation ETF has experienced continuous net inflows over the past six days, with a peak single-day net inflow of 40.54 million yuan, totaling 84.99 million yuan, averaging 14.17 million yuan in daily net inflow [1] - The biopharmaceutical sector has seen a rapid increase in interest, particularly following the outbreak of the Nipah virus in West Bengal, India, prompting heightened preventive measures in Thailand and Nepal [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the China Securities Pharmaceutical and Medical Device Innovation Index include WuXi AppTec, Hengrui Medicine, and Mindray Medical, collectively accounting for 63.75% of the index [2]
印度暴发尼帕病毒疫情，医疗创新ETF(516820)持续获资金关注
Xin Lang Cai Jing·2026-01-26 05:43